Editorial Commentary: Shall We Disregard Mannose-Binding Lectin Modification in the Future Because We Cannot Prevent Sepsis With This Molecule?

Affiliations

¹ Victorian Infectious Diseases Service at the Peter Doherty Institute, Melbourne Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia.

Editorial

Damon P Eisen. Clin Infect Dis. 2015.

. 2015 Sep 1;61(5):704-6.

doi: 10.1093/cid/civ380. Epub 2015 May 12.

¹ Victorian Infectious Diseases Service at the Peter Doherty Institute, Melbourne Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia.

No abstract available

Keywords: deficiency; innate immunity; mannose-binding lectin; sepsis; susceptibility.

Comment on

Variants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European Cohort.
Mills TC, Chapman S, Hutton P, Gordon AC, Bion J, Chiche JD, Holloway PA, Stüber F, Garrard CS, Hinds CJ, Hill AV, Rautanen A; ESICM/ECCRN GenOSept Investigators. Mills TC, et al. Clin Infect Dis. 2015 Sep 1;61(5):695-703. doi: 10.1093/cid/civ378. Epub 2015 May 12. Clin Infect Dis. 2015. PMID: 25969530 Free PMC article.